Subgroup | Number of studies | Intention not to perform FGM/C RR (95% CI) | Heterogeneity | ||
---|---|---|---|---|---|
I2 | p-value | ||||
Study participants | Both key decision makers and others | 12 | 1.28 (0.94, 1.75) | 97.6% | < 0.001 |
Only key decision makers | 7 | 2.19 (1.59, 3.00) | 87.9% | < 0.001 | |
Study design | Randomized | 2 | 1.27 (1.142, 1.41) | 15.3% | 0.277 |
Non randomized | 17 | 1.61 (1.22, 2.10) | 96.7% | < 0.00 | |
Intervention content | Only health education | 11 | 1.35 (0.95, 1.92) | 97.7% | < 0.001 |
Health education and training/advocacy | 8 | 3.75 (2.04, 6.88) | 89.9% | < 0.001 | |
Duration of intervention | Above 12 months | 4 | 1.34 (0.86, 2.09) | 96.2% | < 0.001 |
6–12 months | 4 | 1.14 (0.61, 2.15) | 97.8% | < 0.001 | |
Below 6 months | 11 | 1.28 (1.34, 2.64) | 93.9% | < 0.001 | |
Study setting | Institution based | 8 | 1.81 (1.26, 2.59) | 92.9% | < 0.000 |
Community based | 11 | 1.41 (1.02, 1.94) | 97.5% | < 0.000 | |
Publication Period | 2000–2005 | 6 | 1.55 (0.78, 3.09) | 98.2% | < 0.000 |
2006–2010 | 4 | 1.11 (0.59, 2.08) | 96.9% | < 0.000 | |
2011–2015 | 2 | 2.69 (1.50, 4.84) | 74.1% | 0.050 | |
2016–2020 | 5 | 1.58 (1.32, 1.89) | 75.8% | 0.002 | |
2021 and above | 2 | 2.04 (0.67, 6.22) | 92.2% | < 0.000 | |
Risk of bias | Low | 5 | 1.74 (1.24, 2.43) | 89.7% | < 0.000 |
High | 14 | 1.51 (1.13, 2.02) | 97.2% | < 0.000 | |
Total | 19 | 1.55 (1.24, 1.94) | 96.4% | < 0.000 |